Stabilization of proteins in dry powder formulations using supercritical fluid technology

被引:87
作者
Jovanovic, N
Bouchard, A
Hofland, GW
Witkamp, GJ
Crommelin, DJA
Jiskoot, W [1 ]
机构
[1] Univ Utrecht, UIPS, Fac Pharmaceut Sci, Dept Pharmaceut, NL-3508 TB Utrecht, Netherlands
[2] Delft Univ Technol, Lab Proc Equipment, NL-2628 CA Delft, Netherlands
关键词
protein formulation; protein stability; supercritical fluid drying;
D O I
10.1023/B:PHAM.0000048185.09483.e7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Therapeutic proteins have become essential in the treatment of many diseases. Their formulation in dry form is often required to improve their stability. Traditional freeze-drying or spray-drying processes are often harmful to labile proteins and could be replaced by supercritical fluid (SCF) drying to produce particles with defined physicochemical characteristics in a mild single step. A survey of the current SCF drying processes for proteins is presented to give insight into the effect of SCF drying on protein stability and to identify issues that need further investigation. Methods used for drying aqueous and organic protein solutions are described. In particular, effects of process and formulation parameters on particle formation and protein stability are discussed. Although SCF methodology for drying proteins is still in its infancy, it can provide a serious alternative to existing drying methods for stabilizing proteins.
引用
收藏
页码:1955 / 1969
页数:15
相关论文
共 84 条
[1]  
Andersson M.I., 1999, PCT Patent Application, Patent No. [No. W0 99/52507, 9952507]
[2]   The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody [J].
Andya, JD ;
Maa, YF ;
Costantino, HR ;
Nguyen, PA ;
Dasovich, N ;
Sweeney, TD ;
Hsu, CC ;
Shire, SJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (03) :350-358
[3]  
[Anonymous], [No title captured]
[4]   INTERACTION OF ALCOHOLS WITH PROTEINS [J].
BULL, HB ;
BREESE, K .
BIOPOLYMERS, 1978, 17 (09) :2121-2131
[5]   Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system [J].
Bustami, RT ;
Chan, HK ;
Sweeney, T ;
Dehghani, F ;
Foster, NR .
PHARMACEUTICAL RESEARCH, 2003, 20 (12) :2028-2035
[6]   Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide [J].
Bustami, RT ;
Chan, HK ;
Dehghani, F ;
Foster, NR .
PHARMACEUTICAL RESEARCH, 2000, 17 (11) :1360-1366
[7]  
BUSTAMI RT, 2000, P 5 INT S SUP FLUIDS
[8]   Measurements and modeling of high-pressure phase behavior of binary CO2-amides systems [J].
Byun, HS ;
Kim, NH ;
Kwak, C .
FLUID PHASE EQUILIBRIA, 2003, 208 (1-2) :53-68
[9]   Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques [J].
Caliceti, P ;
Salmaso, S ;
Elvassore, N ;
Bertucco, A .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :195-205
[10]  
CARLFORS J, 2000, Patent No. 0056439